{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T20:14:33Z","timestamp":1784837673392,"version":"3.55.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.idc.2026.02.006","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T12:03:54Z","timestamp":1774958634000},"page":"607-619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Role of Infection Prevention in Preventing the Spread of Vancomycin-Resistant Enterococci in Healthcare Settings"],"prefix":"10.1016","volume":"40","author":[{"given":"Anita","family":"Shallal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Crooker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Zervos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Maki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idc.2026.02.006_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/ice.2019.296","article-title":"Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: summary of data reported to the National Healthcare Safety Network, 2015-2017","volume":"41","author":"Weiner-Lastinger","year":"2020","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.idc.2026.02.006_bib2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1017\/ice.2016.254","article-title":"Incidence and outcomes associated with infections caused by vancomycin-resistant enterococci in the United States: systematic literature review and meta-analysis","volume":"38","author":"Chiang","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.idc.2026.02.006_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jhin.2023.09.008","article-title":"Epidemiology and outcomes of vancomycin-resistant enterococcus infections: a systematic review and meta-analysis","volume":"141","author":"Eichel","year":"2023","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.idc.2026.02.006_bib4","series-title":"Performance standards for antimicrobial susceptibility testing (CLSI M100)","year":"2020"},{"key":"10.1016\/j.idc.2026.02.006_bib5","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1586\/14787210.2014.956092","article-title":"Mechanisms of antibiotic resistance in enterococci","volume":"12","author":"Miller","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.idc.2026.02.006_bib6","article-title":"Enterococcus: understanding their resistance mechanisms, therapeutic challenges, and emerging threats","volume":"17","author":"Hota","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.idc.2026.02.006_bib7","article-title":"Emergence of linezolid-resistant Enterococcus faecium in a tertiary hospital in Copenhagen","volume":"9","author":"Misiakou","year":"2023","journal-title":"Microb Genom"},{"key":"10.1016\/j.idc.2026.02.006_bib8","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/jac\/dkw229","article-title":"Sequential steps of daptomycin resistance in Enterococcus faecium and reversion to hypersusceptibility through IS-mediated inactivation of the liaFSR operon","volume":"71","author":"Sinel","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.idc.2026.02.006_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106215","article-title":"In vitro activity of eravacycline and mechanisms of resistance in enterococci","volume":"56","author":"Boukthir","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.idc.2026.02.006_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11908-017-0589-2","article-title":"Treatment of vancomycin-resistant enterococci: focus on daptomycin","volume":"19","author":"Kohinke","year":"2017","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.idc.2026.02.006_bib11","first-page":"751","article-title":"Resistance in vancomycin-resistant enterococci","volume":"34","author":"Miller","year":"2020","journal-title":"Infect Dis Clin"},{"key":"10.1016\/j.idc.2026.02.006_bib12","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s00508-020-01733-7","article-title":"Risk factors for development of vancomycin-resistant enterococcal bacteremia among VRE colonizers: a retrospective case control study","volume":"133","author":"Kaya","year":"2021","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.idc.2026.02.006_bib13","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1093\/jac\/dky075","article-title":"Duration of exposure to multiple antibiotics is associated with increased risk of VRE bacteraemia: a nested case-control study","volume":"73","author":"Gouliouris","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.idc.2026.02.006_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz519","article-title":"Interplay between patient colonization and environmental contamination with vancomycin-resistant enterococci and their association with patient health outcomes in postacute care","volume":"7","author":"Cassone","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.idc.2026.02.006_bib17","article-title":"The evaluation of risk factors for vancomycin-resistant enterococcus colonization and infection among mixed adult intensive care unit patients","volume":"15","author":"Doganci","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.idc.2026.02.006_bib18","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3390\/antibiotics12040651","article-title":"Trends in antibiotic resistance of nosocomial and community-acquired infections in Italy","volume":"12","author":"Cerini","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.idc.2026.02.006_bib19","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.ajic.2013.05.025","article-title":"Risk factors for and epidemiology of community-onset vancomycin-resistant Enterococcus faecalis in southeast Michigan","volume":"41","author":"Omotola","year":"2013","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.idc.2026.02.006_bib20","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s10096-025-05056-1","article-title":"Description of an Enterococcus faecium genotype vanB outbreak in a hospitalization ward","volume":"44","author":"Andres","year":"2025","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.idc.2026.02.006_bib21","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1093\/cid\/ciz092","article-title":"Multidrug-resistant organisms in hospitals: what is on patient hands and in their rooms?","volume":"69","author":"Mody","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2026.02.006_bib22","doi-asserted-by":"crossref","first-page":"e600","DOI":"10.1016\/S2666-7568(23)00188-5","article-title":"Association of patient clinical and gut microbiota features with vancomycin-resistant enterococci environmental contamination in nursing homes: a retrospective observational study","volume":"4","author":"Wang","year":"2023","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/j.idc.2026.02.006_bib23","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/jac\/dkt525","article-title":"Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systematic review and meta-analysis","volume":"69","author":"De Angelis","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.idc.2026.02.006_bib24","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1086\/659403","article-title":"Systematic review of measurement and adjustment for colonization pressure in studies of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and clostridium difficile acquisition","volume":"32","author":"Ajao","year":"2011","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.idc.2026.02.006_bib25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13099-018-0259-4","article-title":"Gut colonization with vancomycin-resistant Enterococcus and risk for subsequent enteric infection","volume":"10","author":"Axelrad","year":"2018","journal-title":"Gut Pathog"},{"key":"10.1016\/j.idc.2026.02.006_bib26","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ajic.2013.01.013","article-title":"Modeling the regional spread and control of vancomycin-resistant enterococci","volume":"41","author":"Lee","year":"2013","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.idc.2026.02.006_bib27","doi-asserted-by":"crossref","first-page":"S214","DOI":"10.1093\/infdis\/jiab184","article-title":"Signal versus noise: how to analyze the microbiome and make progress on antimicrobial resistance","volume":"223","author":"Golob","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.idc.2026.02.006_bib28","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw133","article-title":"Clearance of vancomycin-resistant enterococcus concomitant with administration of a microbiota-based drug targeted at recurrent Clostridium difficile infection","volume":"3","author":"Dubberke","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.idc.2026.02.006_bib29","author":"Siegel"},{"key":"10.1016\/j.idc.2026.02.006_bib30","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1017\/ice.2015.156","article-title":"Reconsidering contact precautions for endemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus","volume":"36","author":"Morgan","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.idc.2026.02.006_bib31","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ajic.2017.08.031","article-title":"Discontinuing contact precautions for multidrug-resistant organisms: a systematic literature review and meta-analysis","volume":"46","author":"Marra","year":"2018","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.idc.2026.02.006_bib32","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1093\/cid\/ciaa1603","article-title":"Effectiveness of contact precautions to prevent transmission of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in intensive care units","volume":"72","author":"Khader","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2026.02.006_bib33","first-page":"1571","article-title":"Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trial","volume":"310","author":"Harris","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.idc.2026.02.006_bib34","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1186\/s12879-018-3388-y","article-title":"Mathematical modelling of vancomycin-resistant enterococci transmission during passive surveillance and active surveillance with contact isolation highlights the need to identify and address the source of acquisition","volume":"18","author":"Cheah","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.idc.2026.02.006_bib35","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13756-019-0628-x","article-title":"Vancomycin-resistant enterococci (VRE) screening and isolation in the general medicine ward: a cost-effectiveness analysis","volume":"8","author":"Mac","year":"2019","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.idc.2026.02.006_bib36","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1093\/cid\/ciaa009","article-title":"Discontinuing contact precautions for vancomycin-resistant enterococcus (VRE) is associated with rising vre bloodstream infection rates in Ontario hospitals, 2009-2018: a quasi-experimental study","volume":"71","author":"Johnstone","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2026.02.006_bib37","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1017\/ice.2018.93","article-title":"Noninfectious hospital adverse events decline after elimination of contact precautions for MRSA and VRE","volume":"39","author":"Martin","year":"2018","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.idc.2026.02.006_bib38","doi-asserted-by":"crossref","first-page":"178","DOI":"10.12788\/jhm.3126","article-title":"Things we do for no reason: contact precautions for MRSA and VRE","volume":"14","author":"Young","year":"2019","journal-title":"J Hosp Med"},{"key":"10.1016\/j.idc.2026.02.006_bib39","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jhin.2018.02.017","article-title":"Active surveillance for carbapenem-resistant Enterobacteriaceae, vancomycin-resistant enterococci and toxigenic Clostridium difficile among patients transferred from long-term care facilities in Korea","volume":"99","author":"Hwang","year":"2018","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.idc.2026.02.006_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jhin.2022.11.017","article-title":"Impact of discontinuing isolation in a private room for patients infected or colonized with vancomycin-resistant enterococci (VRE) on the incidence of healthcare-associated VRE bacteraemia in a hospital with a predominantly shared-room setting","volume":"132","author":"Chang","year":"2023","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.idc.2026.02.006_bib41","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ajic.2020.11.020","article-title":"Does the removal of contact precautions for MRSA and VRE infected patients change health care-associated infection rate?: a systematic review and meta-analysis","volume":"49","author":"Kleyman","year":"2021","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.idc.2026.02.006_bib42","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ijid.2010.05.002","article-title":"Infection control: the case for horizontal rather than vertical interventional programs","volume":"14","author":"Wenzel","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.idc.2026.02.006_bib43","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.ajic.2020.06.219","article-title":"Stopping the routine use of contact precautions for management of MRSA and VRE at three academic medical centers: an interrupted time series analysis","volume":"48","author":"Haessler","year":"2020","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.idc.2026.02.006_bib44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s15010-018-1202-9","article-title":"Vancomycin-resistant enterococci (VRE): a reason to isolate?","volume":"47","author":"Vehreschild","year":"2019","journal-title":"Infection"},{"key":"10.1016\/j.idc.2026.02.006_bib45","article-title":"Contact precautions for MRSA and VRE: where are we now? A survey of the Society for Healthcare Epidemiology of America Research Network","volume":"4","author":"Martin","year":"2024","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"10.1016\/j.idc.2026.02.006_bib46","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5578\/mb.20250189","article-title":"Effects of chlorhexidine gluconate bathing applied to cancer patients on MRSA and VRE colonization: a cross-over design study [in Turkish]","volume":"59","author":"Tarak\u00e7io\u011flu \u00c7elik","year":"2025","journal-title":"Mikrobiyol Bul"},{"key":"10.1016\/j.idc.2026.02.006_bib47","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1097\/PTS.0000000000000743","article-title":"Chlorhexidine bathing strategies for multidrug-resistant organisms: a summary of recent evidence","volume":"16","author":"Gall","year":"2020","journal-title":"J Patient Saf"},{"key":"10.1016\/j.idc.2026.02.006_bib48","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1086\/676533","article-title":"Strategies to prevent central line-associated bloodstream infections in acute care hospitals: 2014 update","volume":"35","author":"Marschall","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.idc.2026.02.006_bib49","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0140-6736(18)32593-5","article-title":"Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause bloodstream infections in general medical and surgical units (ABATE infection trial): a cluster-randomised trial","volume":"393","author":"Huang","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2026.02.006_bib50","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1099\/jmm.0.000642","article-title":"Susceptibility of vancomycin-resistant and -sensitive Enterococcus faecium obtained from Danish hospitals to benzalkonium chloride, chlorhexidine and hydrogen peroxide biocides","volume":"66","author":"Alotaibi","year":"2017","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.idc.2026.02.006_bib51","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1128\/AAC.02595-15","article-title":"Chlorhexidine induces VanA-Type vancomycin resistance genes in Enterococci","volume":"60","author":"Bhardwaj","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idc.2026.02.006_bib52","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1021\/acsmedchemlett.3c00032","article-title":"Evaluation of 1,3,4-thiadiazole carbonic anhydrase inhibitors for gut decolonization of vancomycin-resistant enterococci","volume":"14","author":"Abutaleb","year":"2023","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.idc.2026.02.006_bib53","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/647230","article-title":"Long-term survival of vancomycin-resistant Enterococcus faecium on a contaminated surface","volume":"17","author":"Bonilla","year":"1996","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.idc.2026.02.006_bib54","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1017\/ice.2018.156","article-title":"Transfer of pathogens to and from patients, healthcare providers, and medical devices during care activity-a systematic review and meta-analysis","volume":"39","author":"Wolfensberger","year":"2018","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.idc.2026.02.006_bib55","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1471-2334-7-61","article-title":"Reduction of Clostridium difficile and vancomycin-resistant Enterococcus contamination of environmental surfaces after an intervention to improve cleaning methods","volume":"7","author":"Eckstein","year":"2007","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.idc.2026.02.006_bib56","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/cid\/ciy115","article-title":"Environmental panels as a proxy for nursing facility patients with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus colonization","volume":"67","author":"Cassone","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2026.02.006_bib57","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1086\/527394","article-title":"Prior environmental contamination increases the risk of acquisition of vancomycin-resistant enterococci","volume":"46","author":"Drees","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2026.02.006_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiac.2025.102718","article-title":"Active surveillance of vancomycin-resistant Enterococcus faecium after its outbreak at patient admission","volume":"31","author":"Furuya","year":"2025","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.idc.2026.02.006_bib59","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1086\/676864","article-title":"Vancomycin-resistant enterococcus (VRE) transmission and risk factors in contacts of VRE carriers","volume":"35","author":"Kaki","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.idc.2026.02.006_bib60","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jhin.2024.08.013","article-title":"Cumulative incidence of vancomycin-resistant Enterococcus faecium detection by patient characteristics or possible exposures: prioritization of patients for active screening culture","volume":"154","author":"Furuya","year":"2024","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.idc.2026.02.006_bib61","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jhin.2014.09.002","article-title":"Controlling the spread of vancomycin-resistant enterococci. Is active screening worthwhile?","volume":"88","author":"Humphreys","year":"2014","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.idc.2026.02.006_bib62","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s44259-024-00031-w","article-title":"Antimicrobial stewardship: a definition with a one Health perspective","volume":"2","author":"Hibbard","year":"2024","journal-title":"NPJ Antimicrob Resist"},{"key":"10.1016\/j.idc.2026.02.006_bib63","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jgar.2025.01.016","article-title":"Vancomycin-resistant Enterococcus faecium: a current perspective on resilience, adaptation, and the urgent need for novel strategies","volume":"41","author":"Almeida-Santos","year":"2025","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.idc.2026.02.006_bib64","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13756-024-01498-y","article-title":"Oral vancomycin use and incidence of vancomycin-resistant enterococci: time-series analysis","volume":"13","author":"Bae","year":"2024","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.idc.2026.02.006_bib65","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00052-25","article-title":"Risk factors for vancomycin resistance in patients with Enterococcus faecium bloodstream infections: an analysis of the Munich Multicentric Enterococci Cohort","volume":"13","author":"Wagner","year":"2025","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.idc.2026.02.006_bib66","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3390\/antibiotics14050522","article-title":"Vancomycin-resistant E. faecium: addressing global and clinical challenges","volume":"14","author":"Radford-Smith","year":"2025","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.idc.2026.02.006_bib67","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/cid\/ciz900","article-title":"Antimicrobial stewardship in a hematological malignancy unit: carbapenem reduction and decreased vancomycin-resistant enterococcus infection","volume":"71","author":"Webb","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2026.02.006_bib68","doi-asserted-by":"crossref","first-page":"e01800","DOI":"10.1128\/AAC.01800-18","article-title":"Impact of an antimicrobial stewardship intervention on within- and between-patient daptomycin resistance evolution in vancomycin-resistant Enterococcus faecium","volume":"63","author":"Kinnear","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idc.2026.02.006_bib69","doi-asserted-by":"crossref","DOI":"10.7573\/dic.2022-8-2","article-title":"How to design and implement an outpatient antimicrobial stewardship programme","volume":"12","author":"Drwiega","year":"2023","journal-title":"Drugs Context"},{"key":"10.1016\/j.idc.2026.02.006_bib70","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jhin.2024.09.028","article-title":"Management of vancomycin-resistant Enterococcus faecium in Dutch healthcare institutes: a nationwide survey","volume":"155","author":"Mulder","year":"2025","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.idc.2026.02.006_bib71","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3390\/microorganisms13040822","article-title":"Outbreak of vancomycin-resistant enterococcus in a NICU: insights into molecular detection and infection control","volume":"13","author":"Peracchi","year":"2025","journal-title":"Microorganisms"},{"key":"10.1016\/j.idc.2026.02.006_bib72","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13756-019-0466-x","article-title":"Emergence of vancomycin-resistant enterococci in Switzerland: a nation-wide survey","volume":"8","author":"Buetti","year":"2019","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.idc.2026.02.006_bib73","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01978-18","article-title":"Expansion of vancomycin-resistant Enterococcus faecium in an academic tertiary hospital in Southwest Germany: a large-scale whole-genome-based outbreak investigation","volume":"63","author":"Liese","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idc.2026.02.006_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2017.e00473","article-title":"Outbreaks caused by vancomycin-resistant Enterococcus faecium in hematology and oncology departments: a systematic review","volume":"3","author":"Ulrich","year":"2017","journal-title":"Heliyon"},{"key":"10.1016\/j.idc.2026.02.006_bib75","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13756-023-01350-9","article-title":"Description of a nationwide structure for monitoring nosocomial outbreaks of (highly resistant) microorganisms in the Netherlands: characteristics of outbreaks in 2012-2021","volume":"12","author":"Woudt","year":"2023","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.idc.2026.02.006_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.cegh.2024.101663","article-title":"Vancomycin-resistant enterococci: a rising challenge to global health","volume":"28","author":"Iqbal","year":"2024","journal-title":"Clinical Epidemiology and Global Health"},{"key":"10.1016\/j.idc.2026.02.006_bib77","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1017\/ash.2022.365","article-title":"Costs of two vancomycin-resistant enterococci outbreaks in an academic hospital","volume":"3","author":"van der Pol","year":"2023","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"10.1016\/j.idc.2026.02.006_bib78","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.48.2200285","article-title":"Nosocomial outbreak of vancomycin-resistant Enterococcus faecium (VRE) ST796, Switzerland, 2017 to 2020","volume":"27","author":"Piezzi","year":"2022","journal-title":"Euro Surveill"},{"key":"10.1016\/j.idc.2026.02.006_bib79","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.3390\/microorganisms10081603","article-title":"Controlling an unprecedented outbreak with vancomycin-resistant Enterococcus faecium in Germany, October 2015 to November 2019","volume":"10","author":"Bender","year":"2022","journal-title":"Microorganisms"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552026000309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552026000309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:46:25Z","timestamp":1784835985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552026000309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0891552026000309"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2026.02.006","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Infection Prevention in Preventing the Spread of Vancomycin-Resistant Enterococci in Healthcare Settings","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2026.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}